These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 6599674)
1. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats. Berecek KH; Mah SC; Baum P; Hofbauer KG J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674 [TBL] [Abstract][Full Text] [Related]
2. Vasopressin: mechanism of central cardiovascular action in conscious rats. Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805 [TBL] [Abstract][Full Text] [Related]
3. Role of endothelin and vasopressin in DOCA-salt hypertension. Yu M; Gopalakrishnan V; McNeill JR Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238 [TBL] [Abstract][Full Text] [Related]
4. Increased cardiovascular responsiveness to GABAergic stimulation in DOCA-salt hypertensive rats. Magrì V; Trimarchi GR; Quattrone G; Squadrito F; Di Giorgio RM; Costa G; Caputi AP Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):107-18. PubMed ID: 6433410 [TBL] [Abstract][Full Text] [Related]
5. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676 [TBL] [Abstract][Full Text] [Related]
6. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722 [TBL] [Abstract][Full Text] [Related]
7. Sympathetic activation following central vasopressin receptor stimulation in conscious rats. Unger T; Rohmeiss P; Becker H; Ganten D; Lang RE; Petty M J Hypertens Suppl; 1984 Dec; 2(3):S25-7. PubMed ID: 6100738 [TBL] [Abstract][Full Text] [Related]
8. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats. Styś T; Szczepańska-Sadowska E J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233 [TBL] [Abstract][Full Text] [Related]
9. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release. Chen YF; Jin HK; Paul R; Nagahama S J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976 [TBL] [Abstract][Full Text] [Related]
10. Augmented vasodepressor and sympathetic responses to intracerebroventricular injections of diltiazem, a calcium channel blocker, in DOCA-salt hypertensive rats. Takahashi H; Okabayashi H; Suga K; Iyoda I; Matsuzawa M; Ikegaki I; Yoshimura M; Ijichi H J Hypertens Suppl; 1986 Dec; 4(6):S156-9. PubMed ID: 3475411 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Savci V; Cavun S; Goktalay G; Ulus IH Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of injection of argipressin into lateral septal nuclei in rats. Gao L; Jiang NC; Luo QH; Zhu ZX Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):49-52. PubMed ID: 8737453 [TBL] [Abstract][Full Text] [Related]
13. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II. Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats. Jochem J; Zwirska-Korczala K; Zabielski R; Kato I; Kuwahara A J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():115-24. PubMed ID: 17244943 [TBL] [Abstract][Full Text] [Related]
15. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. Feuerstein G; Zerbe RL; Faden AI J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114 [TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors. Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306 [TBL] [Abstract][Full Text] [Related]
17. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. Wang YX; Pang CC J Pharmacol Exp Ther; 1993 Apr; 265(1):263-72. PubMed ID: 7682612 [TBL] [Abstract][Full Text] [Related]
18. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203 [TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats. Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409 [TBL] [Abstract][Full Text] [Related]
20. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]